Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants fast track designation for PaxVax's chikungunya VLP vaccine

May 7, 2018

MenoGeniX receives grant from NIA for drug to treat menopausal hot flashes

May 7, 2018

Sarepta partners with Myonexus to advance gene therapies for limb-girdle muscular dystrophy

May 4, 2018

EMA validates type II variation application for Opdivo plus Yervoy in first-line NSCLC

May 4, 2018

OTL-200 receives rare pediatric disease designation from the FDA

May 4, 2018

Casma Therapeutics launched to develop breakthrough therapies by boosting autophagy

May 4, 2018

DLK inhibitor shows promising data in vivo

May 4, 2018

First patient dosed in phase II study of AG-10 in ATTR cardiomyopathy

May 4, 2018

Altum Pharmaceuticals acquires Lexi Pharma

May 4, 2018

FDA approves AndexXa to reverse factor Xa inhibitors

May 4, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...